Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act

United States116e CongrèsHR-2115House of Representatives
Mis à jour : 29 oct. 2019

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Consulter le texte officiel

3 versions disponibles

Tous les dossiers disponibles sont affichés.

Chronologie

  1. On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 403 - 0 (Roll no. 586). (text: CR H8516)

    House of Representatives

    Voir le vote

  2. Motion to reconsider laid on the table Agreed to without objection.

    House of Representatives

  3. The title of the measure was amended. Agreed to without objection.

    House of Representatives

  4. Received in the Senate and Read twice and referred to the Committee on Finance.

    Senate